Potassium Carbonate → 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine

HRID 719960

反応式

HRID 719960 の反応式
[CH3:1][C:2]1([CH3:20])[O:6][C@@H:5]([C:7]2[N:8]=[CH:9][C:10]([NH:13]C(=O)C(C)(C)C)=[N:11][CH:12]=2)[CH2:4][O:3]1.C(=O)([O-])[O-].[K+].[K+]>CO>[CH3:1][C:2]1([CH3:20])[O:6][C@@H:5]([C:7]2[N:8]=[CH:9][C:10]([NH2:13])=[N:11][CH:12]=2)[CH2:4][O:3]1

参加物

4

反応条件

温度
25 °C

実験手順

A mixture of N-[5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-yl]-2,2-dimethyl-propionamide (8.4 g, 30.7 mmol) and potassium carbonate (4.32 g, 31.2 mmol) in methanol (150 mL) was stirred at 25° C. for 16.5 h, at which time, thin layer chromatography suggested partial conversion to a more polar product. In an effort to avoid epimerization at the stereogenic center, the reaction was discontinued before completion. Therefore, the solvent was removed under reduced pressure at 25° C. The resulting residue was again concentrated in vacuo from ethyl acetate (50 mL). The material was purified using Biotage chromatography (FLASH 40L, Silica, ethyl acetate). The early fractions collected allowed for the recovery of unreacted starting pivaloylamide as a white solid (2.0 g, 24%). The later fractions were concentrated in vacuo to provide 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine (3.7 g, 63%) as a pale yellow oil. High-performance liquid chromatography analysis with a chiral column indicated 100% ee.

後処理

  1. customTherefore, the solvent was removed under reduced pressure at 25° C
  2. concentrationThe resulting residue was again concentrated in vacuo from ethyl acetate (50 mL)
  3. customThe material was purified
  4. customThe early fractions collected
  5. concentrationThe later fractions were concentrated in vacuo

出典と根拠

ORDレコード
ord-c2184ca025d24d44ac3d7c2bf2d7f605
出典データセット
uspto-grants-2006_11
特許番号
US07132425B2

関連ノート

読み込み中…